A model for gene therapy of human hereditary lymphedema-Reference-Cited by-同舟云学术

A model for gene therapy of human hereditary lymphedema

Published:2001-10-09 Issue:22 Volume:98 Page:12677-12682
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proceedings of the National Academy of Sciences

Author:

Karkkainen M. J.,Saaristo A.,Jussila L.,Karila K. A.,Lawrence E. C.,Pajusola K.,Bueler H.,Eichmann A.,Kauppinen R.,Kettunen M. I.,Yla-Herttuala S.,Finegold D. N.,Ferrell R. E.,Alitalo K.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference41 articles.

1. Hereditary lymphedema: evidence for linkage and genetic heterogeneity

2. Mapping of Primary Congenital Lymphedema to the 5q35.3 Region

3. Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema

4. Congenital Hereditary Lymphedema Caused by a Mutation That Inactivates VEGFR3 Tyrosine Kinase

Cited by 515 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular pathophysiology of secondary lymphedema;Frontiers in Cell and Developmental Biology;2024-07-08

2. Targeting lymphatic function in cardiovascular-kidney-metabolic syndrome: preclinical methods to analyze lymphatic function and therapeutic opportunities;Frontiers in Cardiovascular Medicine;2024-06-10

3. Loss-of-function mutations of the TIE1 receptor tyrosine kinase cause late-onset primary lymphedema;Journal of Clinical Investigation;2024-05-30

4. Lymphatic-Dependent Modulation of the Sensitization and Elicitation Phases of Contact Hypersensitivity;Journal of Investigative Dermatology;2024-03

5. Lymphatic Tissue Engineering and Regeneration;Advanced Targeting of the Lymphatic System;2024